To include your compound in the COVID-19 Resource Center, submit it here.

Trius, Bayer deal

Trius granted Bayer exclusive rights to antibiotic candidate torezolid in China, Japan, Africa, Latin America, the Middle East, and all

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE